Transmembrane activator and CAML interactor (TACI), also known as tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) is a protein that in humans is encoded by the TNFRSF13B gene
TNFRSF13B is a transmembrane protein of the TNF receptor superfamily found predominantly on the surface of B cells, which are an important part of the immune system. TACI recognizes three ligands: APRIL, BAFF and CAML.
TACI is a lymphocyte-specific member of the tumor necrosis factor (TNF) receptor superfamily. It was originally discovered because of its ability to interact with calcium-modulator and cyclophilin ligand (CAML). TACI was later found to play a crucial role in humoral immunity by interacting with two members of the TNF family: BAFF and APRIL. These proteins signal through TACI inducing activation of several transcription factors including NFAT, AP-1, and NF-kappa-B which then modulate cellular activities. Defects in the function of TACI can lead to immune system diseases.
TACI mutations are associated with immunodeficiency in humans, as a significant proportion of CVID patients have TACI mutations. People with this condition produce abnormally low amounts of antibodies, which are needed for protection against infections.
In humans, the gene encoding this protein is located within the Smith-Magenis syndrome region on chromosome 17.
^ abWu Y, Bressette D, Carrell JA, Kaufman T, Feng P, Taylor K et al. (Nov 2000). "Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS". The Journal of Biological Chemistry275 (45): 35478–85. doi:10.1074/jbc.M005224200. PMID10956646.
Salzer U, Jennings S, Grimbacher B (Jan 2007). "To switch or not to switch--the opposing roles of TACI in terminal B cell differentiation". European Journal of Immunology37 (1): 17–20. doi:10.1002/eji.200636914. PMID17171762.
Maruyama K, Sugano S (Jan 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene138 (1-2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
von Bülow GU, Bram RJ (Oct 1997). "NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily". Science278 (5335): 138–41. doi:10.1126/science.278.5335.138. PMID9311921.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (Oct 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene200 (1-2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K et al. (Apr 2000). "TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease". Nature404 (6781): 995–9. doi:10.1038/35010115. PMID10801128.
Yan M, Marsters SA, Grewal IS, Wang H, Ashkenazi A, Dixit VM (Jul 2000). "Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity". Nature Immunology1 (1): 37–41. doi:10.1038/76889. PMID10881172.
Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A (Jun 2000). "Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI". Current Biology10 (13): 785–8. doi:10.1016/S0960-9822(00)00566-2. PMID10898980.
von Bülow GU, Russell H, Copeland NG, Gilbert DJ, Jenkins NA, Bram RJ (Aug 2000). "Molecular cloning and functional characterization of murine transmembrane activator and CAML interactor (TACI) with chromosomal localization in human and mouse". Mammalian Genome11 (8): 628–32. doi:10.1007/s003350010125. PMID10920230.
Wu Y, Bressette D, Carrell JA, Kaufman T, Feng P, Taylor K et al. (Nov 2000). "Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS". The Journal of Biological Chemistry275 (45): 35478–85. doi:10.1074/jbc.M005224200. PMID10956646.
Yu G, Boone T, Delaney J, Hawkins N, Kelley M, Ramakrishnan M et al. (Sep 2000). "APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity". Nature Immunology1 (3): 252–6. doi:10.1038/79802. PMID10973284.
Novak AJ, Darce JR, Arendt BK, Harder B, Henderson K, Kindsvogel W et al. (Jan 2004). "Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival". Blood103 (2): 689–94. doi:10.1182/blood-2003-06-2043. PMID14512299.
Hymowitz SG, Patel DR, Wallweber HJ, Runyon S, Yan M, Yin J et al. (Feb 2005). "Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding". The Journal of Biological Chemistry280 (8): 7218–27. doi:10.1074/jbc.M411714200. PMID15542592.
Castigli E, Wilson SA, Garibyan L, Rachid R, Bonilla F, Schneider L et al. (Aug 2005). "TACI is mutant in common variable immunodeficiency and IgA deficiency". Nature Genetics37 (8): 829–34. doi:10.1038/ng1601. PMID16007086.